Skip to main content

Data Requests to Use Johnson and Johnson Data

Requests listing last updated January 23, 2020

Approved Requests

The YODA Project posts approved proposals once data access has been granted.

34 Results
YODA PROJECT Protocol Number2018-3121
Product(s) of Interest
REMICADE® (Infliximab), SIMPONI® (Golimumab)
No. Trials Provided6
Complete
Principal InvestigatorSiddharth Singh
Divison of Gastroenterology, University of California San Diego
Reports & Publications
YODA PROJECT Protocol Number2017-2306
Product(s) of Interest
SIMPONI® (Golimumab), REMICADE® (Infliximab)
No. Trials Provided5
Complete
Principal InvestigatorSiddharth Singh
Divison of Gastroenterology, University of California San Diego
Reports & Publications
YODA PROJECT Protocol Number2017-2031
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided3
YODA PROJECT Protocol Number2017-1746
Product(s) of Interest
REMICADE® (Infliximab), RAZADYNE® (Galantamine), INVOKANA® (Canagliflozin), SIMPONI® (Golimumab), TOPAMAX® (Topiramate), STELARA® (Ustekinumab), RISPERDAL® (Risperidone)
No. Trials Provided43
YODA PROJECT Protocol Number2017-1706
Product(s) of Interest
STELARA® (Ustekinumab)
No. Trials Provided2
YODA PROJECT Protocol Number2017-1701
Product(s) of Interest
RISPERDAL® (Risperidone), INVEGA SUSTENNA® (Paliperidone palmitate)
No. Trials Provided6
YODA PROJECT Protocol Number2017-1676
Product(s) of Interest
INVEGA® (Paliperidone), RISPERDAL® (Risperidone)
No. Trials Provided11
Complete
Principal InvestigatorHiroyuki Uchida
Keio University School of Medicine, Department of Neuropsychiatry
Reports & Publications
YODA PROJECT Protocol Number2016-1176
Product(s) of Interest
STELARA® (Ustekinumab)
No. Trials Provided3
YODA PROJECT Protocol Number2016-1122
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided1
YODA PROJECT Protocol Number2016-1103
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided2
YODA PROJECT Protocol Number2016-1057
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided2
YODA PROJECT Protocol Number2016-0912
Product(s) of Interest
THERMOCOOL® SMARTTOUCH™ Catheter (Ablation Catheter)
No. Trials Provided1
YODA PROJECT Protocol Number2016-0897
Product(s) of Interest
STELARA® (Ustekinumab)
No. Trials Provided2
YODA PROJECT Protocol Number2016-0880
Product(s) of Interest
INVEGA SUSTENNA® (Paliperidone palmitate), INVEGA® (Paliperidone), RISPERDAL CONSTA® (Risperidone), RISPERDAL® (Risperidone)
No. Trials Provided49
Complete
Principal InvestigatorStefan Leucht
Department of Psychiatry and Psychotherapy, Klinikum rechts der Isar, Technische Universität München
YODA PROJECT Protocol Number2016-0734
Product(s) of Interest
SIRTURO® (Bedaquiline/TMC207)
No. Trials Provided2
YODA PROJECT Protocol Number2016-0716
Product(s) of Interest
INVEGA®
No. Trials Provided1
YODA PROJECT Protocol Number2015-0678
Product(s) of Interest
INVEGA®
No. Trials Provided1
Complete
Principal InvestigatorSharon-Lise Normand
Harvard Medical School
YODA PROJECT Protocol Number2015-0617
Product(s) of Interest
INVEGA®
No. Trials Provided1
Complete
Principal InvestigatorKarestan Koenen
Harvard School of Public Health
Reports & Publications
YODA PROJECT Protocol Number2015-0612
Product(s) of Interest
STELARA® (Ustekinumab), REMICADE® (Infliximab), SIMPONI® (Golimumab)
No. Trials Provided16
YODA PROJECT Protocol Number2015-0514
Product(s) of Interest
LEVAQUIN® (Levofloxacin)
No. Trials Provided1
YODA PROJECT Protocol Number2014-0401
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided1
YODA PROJECT Protocol Number2014-0340
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided9
YODA PROJECT Protocol Number2014-0334
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided4
YODA PROJECT Protocol Number2014-0291
Product(s) of Interest
SIMPONI® (Golimumab), REMICADE® (Infliximab)
No. Trials Provided3
Complete
Principal InvestigatorMichael Ward
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Reports & Publications
YODA PROJECT Protocol Number2020-4211
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided6
Approved Pending DUA Signature
Principal InvestigatorLinong Ji
Peking University People's Hospital
YODA PROJECT Protocol Number2019-4093
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided2
Approved with DUA Signature
Principal InvestigatorBasem Mishriky
East Carolina Univereseity
YODA PROJECT Protocol Number2019-4092
Product(s) of Interest
SIMPONI® (Golimumab), REMICADE® (Infliximab)
No. Trials Provided11
Approved Pending DUA Signature
Principal InvestigatorTianxi Cai
Department of Biostatistics, Harvard T.H. Chan School of Public Health
YODA PROJECT Protocol Number2019-4075
Product(s) of Interest
OPSUMIT® (Macitentan), UPTRAVI® (Selexipag), TRACLEER® (Bosentan)
No. Trials Provided5
Approved Pending DUA Signature
Principal InvestigatorRaymond Benza
Allegheny Health Network
YODA PROJECT Protocol Number2019-4071
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided15
Approved Pending DUA Signature
Principal InvestigatorFrank Moriarty
Royal College of Surgeons in Ireland
YODA PROJECT Protocol Number2019-4067
Product(s) of Interest
SIMPONI® (Golimumab), REMICADE® (Infliximab), STELARA® (Ustekinumab)
No. Trials Provided45
Approved Pending DUA Signature
Principal InvestigatorFlorence Bourgeois
Harvard Medical School
YODA PROJECT Protocol Number2019-4066
Product(s) of Interest
SIMPONI® (Golimumab)
No. Trials Provided1
Approved Pending DUA Signature
Principal InvestigatorPhilip Robinson
University of Queensland
YODA PROJECT Protocol Number2019-4035
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided2
YODA PROJECT Protocol Number2019-4015
Product(s) of Interest
PLIVENSIA (Sirukumab)
No. Trials Provided2
Approved Pending DUA Signature
Principal InvestigatorJohn Peipert
Northwestern University
YODA PROJECT Protocol Number2019-3829
Product(s) of Interest
DOXIL® (Doxorubicin hydrochloride)
No. Trials Provided2
Approved with DUA Signature
Principal InvestigatorLee Van Horn
University of New Mexico